NFE2L2 and cancer: Our data here uncover that activation of NRF2 by ZMYND8 triggers an active defense system allowing BCSCs to better cope with potential oxidative stress and ferroptosis for survival and stemness, suggesting that the role of NRF2 is highly dependent on the cellular and environmental context in human cancers.